💨 Abstract

Researchers at Weill Cornell Medicine and the New York Genome Center have developed a novel, error-corrected technique for identifying cancer from blood samples. This method, based on whole-genome sequencing, is significantly more sensitive and accurate than previous methods and could be used to monitor patients' disease status following treatment. The technique is a step towards routine blood test-based screening for early cancer detection.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖